RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

I've been encouraged by the RD buyback agreement. Bundled together with SA and Sickle Cell, they could well have the funds to finally attack ADHD. It will be tough to raise 2-3 million at this share price to buy them enough time to negotiate without significant dilution. Despite the cost to shareholders, I'm confident management will opt. for whatever financing deal they can obtain, since I don't believe they would sell the company even if they could obtain the much mentioned price of .50 share (how that figure has gained legitimacy through repetition is also an interesting subject for speculation.)
I don't think the FDA has it in for CORX. They are a death star for the hopes and dreams of pharma shareholders everywhere. Just ask former Amylin bull Jim Cramer. At any rate CORX is not at the point of even having to worry about the FDA. Just obtaining enough funding to negotiate the sale of assets will be challenge enough.
Although its nice to see the SP not go down on news of RD repatriation, I remain on the sidelines until the financing details are announced.